Black Diamond Therapeutics Inc (BDTX)

2.15 -0.04 (-1.83%) USD  |  NASDAQ  |  Dec 24, 11:55
More

Black Diamond Therapeutics Enterprise Value: 11.24M for Dec. 23, 2024

Enterprise Value Chart

View Enterprise Value for BDTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Enterprise Value Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Enterprise Value Definition

View Enterprise Value Definition
Start Trial

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Vanda Pharmaceuticals Inc -103.38M
IDEAYA Biosciences Inc 1.274B
NovaBay Pharmaceuticals Inc 1.805M
Palatin Technologies Inc 16.58M
iBio Inc 11.49M

Enterprise Value Related Metrics

Net Income (Quarterly) -15.56M
Total Expenses (Quarterly) 18.13M
EPS Diluted (Quarterly) -0.28
Earnings Yield -61.86%